Clinical trial
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
NCT00078845
Study timeline
Study start (unknown)2004-05-01Date precision: month
Registry last updated2012-10-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Lung Cancerunresolved
Neurotoxicityunresolved
Ovarian Cancerunresolved
Prostate Cancerunresolved
Interventions
AmifostineDRUG · verified · RxNorm: amifostine
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
HoustonTexas, United States1ColumbusOhio, United States1Kansas CityMissouri, United States1WichitaKansas, United States1TacomaWashington, United States1SpartanburgSouth Carolina, United States1Grand RapidsMichigan, United States1SpringfieldMissouri, United States1KalamazooMichigan, United States1UrbanaIllinois, United States1DecaturIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00078845 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.